194
Results-
Press ReleaseKinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre LaboratoriesCreated on : - Last modified on :• Kinnate has entered into an Asset Purchase Agreement (the “APA”) with Pierre Fabre Laboratories for global rights to exarafenib and other pan-RAF program assets.• The transaction is in furtherance of Kinnate’s previously announced pursuit of strategic alternatives.
-
Acting in Full Transparency with the Green Impact Index ConsortiumCreated on : - Last modified on :
The labeling tool that gives you a clear picture of the environmental and social impacts of our products, based on an easy-to-understand score: A+B+C+D+E.
-
Privacy policy and cookies policyCreated on : - Last modified on :Privacy policy and cookies policy Thank you for visiting Our Website. Ensuring data protection and data security for our customers and users is a top priority for us at Pierre Fabre. This privacy policy explains what data is collected when you visit and use our website and how they are processed.
-
Job offersCreated on : - Last modified on :
-
2023 Annual report of Pierre Fabre groupCreated on : - Last modified on :
-
Committed to Fighting Cancer Alongside PatientsCreated on : - Last modified on :
-
Pierre Fabre in the WorldCreated on : - Last modified on :
The Pierre Fabre group operates in 43 locations. Openness to the international markets has always been at the heart of our strategy.
-
Acting Alongside PatientsCreated on : - Last modified on :
Helping improve quality of life
-
Legal noticesCreated on : - Last modified on :Legal notices Editor Pierre Fabre S.A Incorporated as a French limited company with registered capital of €272 416 657,50 Listed with the Registre du Commerce et des Sociétés (RCS) in Paris under the number B 662.006.170 12 Zone Industrielle de la Chartreuse 81100 Castres FRANCE Tel: +33 (0)5 63.62.38.50 Editorial Director Marc Alias Webmaster To contact the webmaster, click HERE
-
Stories of InnovationCreated on : - Last modified on :
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.